Citations

Showing 10 of 108083 citations.

Protease activated receptor 2 controls myelin development, resiliency and repair
Yoon, Hyesook, Walters, Grant C. , Paulsen, Alex R., Drucker, Kristen , Starski, Phillip , Fairlie, David P. , Scarisbrick, Isobel A. , Radulovic, Maja, Scarisbrick, Isobel A , Drucker, Kristen L , Radulovic, Maja , Wu, Jianmin

Mayo Clinic

Glia | September 18, 2017 | Volume: 65 | Issue: 12 | Pages: 2070-2086

10.1002/glia.23215 | PMID 28921694 Get It

AbstractOligodendrocytes are essential regulators of axonal energy homeostasis and electrical conduction and emerging target cells for restoration of neurological function. Here we investigate the role of protease activated receptor 2 (PAR2), a unique protease activated G protein‐coupled receptor, in myelin development and repair using the spinal cord as a model. Results demonstrate that genetic deletion of PAR2 accelerates myelin production, including higher proteolipid protein (PLP) levels in the spinal cord at birth and higher levels of myelin basic protein and thickened myelin sheaths in adulthood. Enhancements in spinal cord myelin with PAR2 loss‐of‐function were accompanied by increased numbers of Olig2‐ and CC1‐positive oligodendrocytes, as well as in levels of cyclic adenosine monophosphate (cAMP), and extracellular signal related kinase 1/2 (ERK1/2) signaling. Parallel promyelinating effects were observed after blocking PAR2 expression in purified oligodendrocyte cultures, whereas inhibiting adenylate cyclase reversed these effects. Conversely, PAR2 activation reduced PLP expression and this effect was prevented by brain derived neurotrophic factor (BDNF), a promyelinating growth factor that signals through cAMP. PAR2 knockout mice also showed improved myelin resiliency after traumatic spinal cord injury and an accelerated pattern of myelin regeneration after focal demyelination. These findings suggest that PAR2 is an important controller of myelin production and regeneration, both in the developing and adult spinal cord.
Use of a radial projection to reduce the statistical uncertainty of spot lateral profiles generated by Monte Carlo simulation
Ding, Xiaoning, Shen, Jiajian , Stoker, Joshua B., Hu, Yanle , Bues, Martin , Anand, Aman, Shen, Jiajian , Bues, Martin , Liu, Wei , Anand, Aman Raj

Mayo Clinic

Journal of Applied Clinical Medical Physics | September 18, 2017 | Volume: 18 | Issue: 6 | Pages: 88-96

10.1002/acm2.12184 | PMID 28921881 Get It

AbstractMonte Carlo (MC) simulation has been used to generate commissioning data for the beam modeling of treatment planning system (TPS). We have developed a method called radial projection (RP) for postprocessing of MC‐simulation‐generated data. We used the RP method to reduce the statistical uncertainty of the lateral profile of proton pencil beams with axial symmetry. The RP method takes advantage of the axial symmetry of dose distribution to use the mean value of multiple independent scores as the representative score. Using the mean as the representative value rather than any individual score results in substantial reduction in statistical uncertainty. Herein, we present the concept and step‐by‐step implementation of the RP method, as well as show the advantage of the RP method over conventional measurement methods for generating lateral profile. Lateral profiles generated by both methods were compared to demonstrate the uncertainty reduction qualitatively, and standard error comparison was performed to demonstrate the reduction quantitatively. The comparisons showed that statistical uncertainty was reduced substantially by the RP method. Using the RP method to postprocess MC data, the corresponding MC simulation time was reduced by a factor of 10 without quality reduction in the generated result from the MC data. We concluded that the RP method is an effective technique to increase MC simulation efficiency for generating lateral profiles for axially symmetric pencil beams.
Diagnostic criteria for adult‐onset leukoencephalopathy with axonal spheroids and pigmented glia due to CSF1R mutation
Yoshida, K., Mizuno, Toshiki , Kawarai, Toshitaka , Tada, Mari , Nozaki, Hiroaki , Ikeda, Shu‐ichi , Onodera, Osamu , Wszołek, Zbigniew K. , Mizuno, T , Kawarai, T , Wszolek, Z.K. , Onodera, Osamu , Konno, Takuya , Mizuta, Ikuko , Ikeuchi, Takeshi

Mayo Clinic

European Journal of Neurology | September 18, 2017 | Volume: 25 | Issue: 1 | Pages: 142-147

10.1111/ene.13464 | PMID 28921817 Get It

Background and purposeTo establish and validate diagnostic criteria for adult‐onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) due to colony‐stimulating factor 1 receptor (CSF1R) mutation.MethodsWe developed diagnostic criteria for ALSP based on a recent analysis of the clinical characteristics of ALSP. These criteria provide ‘probable’ and ‘possible’ designations for patients who do not have a genetic diagnosis. To verify its sensitivity and specificity, we retrospectively applied our criteria to 83 ALSP cases who had CSF1R mutations (24 of these were analyzed at our institutions and the others were identified from the literature), 53 cases who had CSF1R mutation‐negative leukoencephalopathies and 32 cases who had cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) with NOTCH3 mutations.ResultsAmong the CSF1R mutation‐positive cases, 50 cases (60%) were diagnosed as ‘probable’ and 32 (39%) were diagnosed as ‘possible,’ leading to a sensitivity of 99% if calculated as a ratio of the combined number of cases who fulfilled ‘probable’ or ‘possible’ to the total number of cases. With regard to specificity, 22 cases (42%) with mutation‐negative leukoencephalopathies and 28 (88%) with CADASIL were correctly excluded using these criteria.ConclusionsThese diagnostic criteria are very sensitive for diagnosing ALSP with sufficient specificity for differentiation from CADASIL and moderate specificity for other leukoencephalopathies. Our results suggest that these criteria are useful for the clinical diagnosis of ALSP.
Animal models for studying the etiology and treatment of low back pain
Shi, Changgui , Qiu, Sujun , Riester, Scott M. , Das, Vaskar, Zhu, Bingqian , Wallace, Atiyayein A., Wijnen, André J. van , Mwale, Fackson , Iatridis, James C. , Sakai, Daisuke , Votta‐Velis, Gina , Yuan, Wen, Im, Hee‐Jeong , van Wijnen, Andre J , Iatridis, James C , Yuan, Wen

Mayo Clinic

Journal of Orthopaedic Research | September 18, 2017 | Volume: 36 | Issue: 5 | Pages: 1305-1312

10.1002/jor.23741 | PMID 28921656 Get It

ABSTRACTChronic low back pain is a major cause of disability and health care costs. Effective treatments are inadequate for many patients. Animal models are essential to further understanding of the pain mechanism and testing potential therapies. Currently, a number of preclinical models have been developed attempting to mimic aspects of clinical conditions that contribute to low back pain (LBP). This review focused on describing these animal models and the main behavioral tests for assessing pain in each model. Animal models of LBP can be divided into the following five categories: Discogenic LBP, radicular back pain, facet joint osteoarthritis back pain, muscle‐induced LBP, and spontaneous occurring LBP models. These models are important not only for enhancing our knowledge of how LBP is generated, but also for the development of novel therapeutic regimens to treat LBP in patients. © 2017 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 36:1305–1312, 2018.
Increased risk organ transplantation in the pediatric population
Wrenn, Sean M. , Kapoor, Trishul , Aunchman, Alia F, Paine, Adam N., Pineda, Jaime A. , Marroquin, Carlos E. , CALLAS, PETER W. , Pineda, Jaime A.

Mayo Clinic

Pediatric Transplantation | September 18, 2017 | Volume: 21 | Issue: 8 | Pages: No page available

10.1111/petr.13041 | PMID 28921748 Get It

AbstractIRD organs are classified by the Public Health Service to be at above‐average risk for harboring human immunodeficiency virus, hepatitis C, and hepatitis B. Traditionally underutilized, there exists even greater reluctance for their use in pediatric patients. We performed a retrospective analysis via the United Network for Organ Sharing database of all pediatric renal and hepatic transplants performed from 2004 to 2008 in the United States. Primary outcomes were patient and graft survival. Proportional hazards regression was performed to control for potentially confounding factors. Waitlist time, organ acceptance rates, and infectious transmissions were analyzed. There were 1830 SRD renal, 92 IRD renal, 1695 SRD hepatic, and 59 IRD hepatic transplants. There were no statistically significant differences in allograft or patient survival in either group. Acceptance rates of IRD organs were lower for kidney (1.5% IRD vs 4.82% SRD) and liver (1.99% IRD vs 4.51% SRD). One transmission of a bloodborne pathogen involving a pediatric recipient out of 7797 unique transplants was reported from 2008 to 2015. IRD organs appear to have equivalent outcomes. Increasing their utilization may improve access to transplant while decreasing wait times and circumventing waitlist morbidity and mortality.
The reality of de novo malignancy: Sadly, not fake news
Izzy, Manhal , Watt, Kymberly D.

Mayo Clinic

Liver Transplantation | September 18, 2017 | Volume: 23 | Issue: 11 | Pages: 1367-1368

10.1002/lt.24869 | PMID 28921889 Get It

MicroRNA‐506 promotes primary biliary cholangitis–like features in cholangiocytes and immune activation
Erice, Oihane , Muñoz-Garrido, Patricia, Vaquero, Javier , Perugorria, María J. , Fernández‐Barrena, Maite G. , Sáez, Elena , Santos‐Laso, Álvaro , Arbelaiz, Ander, Jiménez-Agüero, Raúl , Fernández‐Irigoyen, Joaquín , Santamaría, Enrique , Torrano, Verónica , Carracedo, Arkaitz , Ananthanarayanan, Meenakshisundaram, Marzioni, Marco , Prìeto, Jesús , Beuers, Ulrich , Bujanda, Luís , Marı́n, José J.G. , Bañales, Jesús M. , Marzioni, Marco , Banales, Jesus M , Elferink, Ronald P.J. Oude , LaRusso, Nicholas F. , Bujanda, L.

Mayo Clinic

Hepatology | September 18, 2017 | Volume: 67 | Issue: 4 | Pages: 1420-1440

10.1002/hep.29533 | PMID 28922472 Get It

Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease associated with autoimmune phenomena targeting intrahepatic bile duct cells (cholangiocytes). Although its etiopathogenesis remains obscure, development of antimitochondrial autoantibodies against pyruvate dehydrogenase complex E2 is a common feature. MicroRNA (miR) dysregulation occurs in liver and immune cells of PBC patients, but its functional relevance is largely unknown. We previously reported that miR‐506 is overexpressed in PBC cholangiocytes and directly targets both Cl – / anion exchanger 2 and type III inositol 1,4,5‐trisphosphate receptor, leading to cholestasis. Here, the regulation of miR‐506 gene expression and its role in cholangiocyte pathophysiology and immune activation was studied. Several proinflammatory cytokines overexpressed in PBC livers (such as interleukin‐8 [IL8], IL12, IL17, IL18, and tumor necrosis factor alpha) stimulated miR‐506 promoter activity in human cholangiocytes, as revealed by luciferase reporter assays. Experimental overexpression of miR‐506 in cholangiocytes dysregulated the cell proteomic profile (by mass spectrometry), affecting proteins involved in different biological processes including mitochondrial metabolism. In cholangiocytes, miR‐506 (1) induced dedifferentiation with down‐regulation of biliary and epithelial markers together with up‐regulation of mesenchymal, proinflammatory, and profibrotic markers; (2) impaired cell proliferation and adhesion; (3) increased oxidative and endoplasmic reticulum stress; (4) caused DNA damage; and (5) sensitized to caspase‐3‐dependent apoptosis induced by cytotoxic bile acids. These events were also associated with impaired energy metabolism in mitochondria (proton leak and less adenosine triphosphate production) and pyruvate dehydrogenase complex E2 overexpression. Coculture of miR‐506 overexpressing cholangiocytes with PBC immunocytes induced activation and proliferation of PBC immunocytes. Conclusion : Different proinflammatory cytokines enhance the expression of miR‐506 in biliary epithelial cells; miR‐506 induces PBC‐like features in cholangiocytes and promotes immune activation, representing a potential therapeutic target for PBC patients. (H epatology 2018;67:1420‐1440)
Complications, symptoms, quality of life and pregnancy in cholestatic liver disease
Zakharia, Kais , Tabibian, Anilga, Lindor, Keith D. , Tabibian, James H. , Tabibian, James H

Mayo Clinic

Liver International | September 18, 2017 | Volume: 38 | Issue: 3 | Pages: 399-411

10.1111/liv.13591 | PMID 28921801 Get It

Abstract Cholestatic liver diseases ( CLD s) encompass a variety of disorders of bile formation and/or flow which generally result in progressive hepatobiliary injury and ultimately end‐stage liver disease. Many patients with CLD are diagnosed between the ages of 20‐50 years, a particularly productive period of life professionally, biologically and in other respects; it is not surprising, thus, that CLD is often associated with impaired health‐related quality of life ( HRQOL ) and uncertainty regarding implications for and outcomes of pregnancy. Primary sclerosing cholangitis ( PSC ) and primary biliary cholangitis ( PBC ) are the most prominent CLD s, both having considerable morbidity and mortality and representing major indications for liver transplantation. These disorders, as a consequence of their complications (eg ascites, hepatic osteodystrophy), associated conditions (eg inflammatory bowel disease) and symptoms (eg pruritus and fatigue), can significantly impair an array of domains of HRQOL . Here we review these impactful clinical aspects of PSC and PBC as well as the topics of fertility and pregnancy.
Guideline of guidelines: asymptomatic microscopic haematuria
Linder, Brian J. , Bass, Edward , Mostafid, Hugh , Boorjian, Stephen A. , Linder, Brian J

Mayo Clinic

BJU International | September 18, 2017 | Volume: 121 | Issue: 2 | Pages: 176-183

10.1111/bju.14016 | PMID 28921833 Get It

The aim of the present study was to review major organizational guidelines on the evaluation and management of asymptomatic microscopic haematuria ( AMH ). We reviewed the haematuria guidelines from: the American Urological Association; the consensus statement by the Canadian Urological Association, Canadian Urologic Oncology Group and Bladder Cancer Canada; the American College of Physicians; the Joint Consensus Statement of the Renal Association and British Association of Urological Surgeons; and the National Institute for Health and Care Excellence. All guidelines reviewed recommend evaluation for AMH in the absence of potential benign aetiologies, with the evaluation including cystoscopy and upper urinary tract imaging. Existing guidelines vary in their definition of AMH (role of urine dipstick vs urine microscopy), the age threshold for recommending evaluation, and the optimal imaging method (computed tomography vs ultrasonography). Of the reviewed guidelines, none recommended the use of urine cytology or urine markers during the initial AMH evaluation. Patients should have ongoing follow‐up after a negative initial AMH evaluation. Significant variation exists among current guidelines for AMH with respect to who should be evaluated and in what manner. Given the patient and health system implications of balancing appropriately focused and effective diagnostic evaluation, AMH represents a valuable future research opportunity.
Implementing evidence-based smoking cessation treatment in psychosocial care units (CAPS) in Brazil
Castaldelli-Maia, João Maurício , Silva, Nilson R da, Campos, Marta RD, Moura, Helena Ferreira , Zabert, Gustavo , Champagne, Beatriz , Kemper, Katherine E. , Hays, J. Taylor , Castaldelli-Maia, João M

Mayo Clinic

International Journal of Social Psychiatry | September 18, 2017 | Volume: 63 | Issue: 8 | Pages: 669-673

10.1177/0020764017731462 | PMID 28920521 Get It

Background: The prevalence of smoking among mental health and addiction (MHA) patients is 3 times higher than it is in the general population, yet this patient population has received little help to combat smoking. Considering this, psychosocial care centers (CAPS – Centros de Atenção Psicossocial) are strategic locations for integrating tobacco dependence treatment (TDT) into existing treatment activities. Methods: Our team provided an 8-hour training package to the staff of CAPS that have not been providing specialized TDT for smokers. Our curriculum included the following topics focused on the implementation of treatment for MHA smokers: management, epidemiology, medications, psychotherapy, and smoking/mental health assessment instruments. Results: Our team trained the staff of 17 CAPS units within 10 cities – which included more than 186 health professionals. There were many barriers encountered as we provided this training. A summary of problems we faced were as follows: resistance to incorporating TDT in addiction/mental health-care units, resistance to the implementation of cognitive-behavioral therapy (CBT) (psychodynamic therapy and harm reduction were preferred) and treatment for smoking is already implemented in primary care network; resistance to the use of medication in addiction treatment (a preference for psychotherapy and psychosocial approach). Conclusion: We learned a number of important lessons as we worked to improve the delivery of TDT to MHA patients in Brazil: provide clinicians an opportunity to explore how they feel/think about providing TDT to their clients at the very outset of the training, rather than focusing on a specific type of behavioral therapy for TDT (such as CBT), which some may find objectionable; use more generic descriptions of behavioral therapy such as ‘supportive counseling’; include training professionals who are open to other forms of behavioral therapy in addition to psychoanalysis and discuss the important impact that MHA units can have in improving the quality of life for their patients who smoke.